Lonza Group reported CHF1.95B in Loan Capital for its first fiscal semester of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Akzo Nobel AKZA:NA EUR 3.36B 42M
Alcon AG ALC:SW USD 4.19B 37M
AstraZeneca AZN:LN USD 23.68B 3.47B
Bayer BAYN:GR EUR 39.46B 1.4B
Covestro 1COV:GR EUR 2.34B 13M
Fresenius FRE:GR EUR 25.24B 607M
Fresenius Medical Care FME:GR EUR 12.41B 930M
Genmab GEN:DC DKK 550M 4M
Givaudan GIVN:VX CHF 4.3B 60M
GlaxoSmithKline GSK:LN GBP 19.32B 538M
Hikma Pharmaceutical HIK:LN USD 1.41B 689M
Johnson Matthey JMAT:LN GBP 1.12B 186M
Merck MRK:GR EUR 9.27B 119M
Novartis NOVN:VX USD 21.24B 2.55B
Philips PHIA:NA EUR 6.91B 122M
Smith & Nephew PLC SN/:LN 2.28B 567M
Solvay SOLB:BB EUR 2.56B 70M
William Demant Holding WDH:DC DKK 4.88B 470M